Monday, October 24, 2016

U.S. FDA approves Merck's lung cancer drug as first-line treatment

… for treating metastatic non-small cell lung cancer (NSCLC) patients with high-levels of … previous chemotherapy for advanced non-small lung cancer.
Monday's announcement gives … only approved first-line treatment for lung cancer, one of the biggest markets …

No comments:

Post a Comment